Few studies have investigated non-target effects of neonicotinoid insecticides on mammalian physiology. This is largely due to the widespread perception that their weak affinity for nicotinic acetylcholine receptor subtypes in vertebrates makes mammalian exposures unlikely to pose health risks. To the best of our knowledge, we This is due to the widespread perception that the general weak affinity of neonicotinoids for nicotinic acetylcholine receptor subtypes in vertebrates makes mammalian exposures unlikely to pose any significant health risks (Sheets et al., 2016) . However, further investigation of health risks is needed as some studies of human populations have found an association between exposure to neonicotinoids and adverse neurodevelopmental effects including teratogenicity and autism spectrum disorder (Cimino, Boyles, Thayer, & Perry, 2017) .
| INTRODUCTION
Neonicotinoids are synthetic insecticides targeting nicotinic acetylcholine receptors in the central nervous system of insects. Their intensive use in agriculture has been associated to a wide range of toxic effects on non-target organisms, including colony collapse in social insects such as honeybees and bumblebees (Henry et al., 2012; Whitehorn, O'Connor, Wackers, & Goulson, 2012) . Although their environmental effects have received a great deal of attention, few studies have investigated the possible effect of neonicotinoids on mammalian physiology. This is due to the widespread perception that the general weak affinity of neonicotinoids for nicotinic acetylcholine receptor subtypes in vertebrates makes mammalian exposures unlikely to pose any significant health risks (Sheets et al., 2016) . However, further investigation of health risks is needed as some studies of human populations have found an association between exposure to neonicotinoids and adverse neurodevelopmental effects including teratogenicity and autism spectrum disorder (Cimino, Boyles, Thayer, & Perry, 2017) .
Biomonitoring reports of neonicotinoid insecticides in human populations are very limited. Nevertheless, a survey of urine from 373 healthy
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This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. © 2018 The Authors Journal of Applied Toxicology Published by John Wiley & Sons Ltd individuals in Japan, detected neonicotinoids in more than half of the samples with an average excretion of 0.51 μg day −1 for clothianidin, 3.29 μg day −1 for dinotefuran, 0.07 μg day −1 for imidacloprid, 0.07 μg day −1 for nitenpyram and 0.18 μg day −1 for thiamethoxam (Harada et al., 2016 Recent advances in endocrinology have linked exposure to pesticides acting as endocrine disruptors to a wide range of serious, negative health effects in humans (Mostafalou & Abdollahi, 2017) . As early investigations concentrated mostly on reproduction problems in wild animals, endocrine disruptive effects of pesticides on the oestrogen and androgen hormone systems have been the most studied (Colborn, vom Saal, & Soto, 1993) . More recently, it has been found that pesticides can provoke neurodevelopmental and neurobehavioural effects by interfering with the action of thyroid hormone (Fini et al., 2017) .
In addition, pesticides can disturb general metabolism, which can cause diabetes and obesity (Heindel et al., 2017) . Pesticides can also act as obesogens by disturbing the activity of retinoid X receptors and peroxisome proliferator-activated receptor gamma (Grun & Blumberg, 2006) . Despite widespread concerns regarding non-target effects of neonicotinoids, no study has described the potential hormone-mimetic properties of this class of compounds.
To address the knowledge gap of the endocrine disrupting capability of neonicotinoids, to the best of our knowledge, we report here the first investigation of the effects of seven principal neonicotinoid insecticides (clothianidin, dinotefuran, flupyradifurone, imidacloprid, nitenpyram, thiacloprid, thiamethoxam) (Figure 1 ) on the oestrogen and thyroid hormone receptor (TR), as well as assessing their adipogenic capability in mammalian cell lines. Our results reveal that none of the neonicotinoids tested displayed either an oestrogenic or thyroidogenic activity but that imidacloprid is a potential obesogen.
| MATERIALS AND METHODS

| Reagents
All reagents and chemicals, unless otherwise specified, were of analytical grade and were purchased from Sigma-Aldrich Ltd (Gillingham, Dorset, UK Thermo Fisher Scientific (Life Technologies)] to avoid spontaneous differentiation to adipocytes. Cells were released from the flask substratum using 0.05% trypsin-EDTA (Life Technologies) and counted using a haemocytometer before re-seeding. A 24 hour recovery FIGURE 1 Molecular structures of the different neonicotinoid insecticides tested in this study period was allowed for cell adherence before cultures were subjected to the desired treatments. Stock solutions of neonicotinoids and the natural hormones dexamethasone, oestradiol and triiodothyronine (T 3 ) were prepared in dimethyl sulphoxide (DMSO). Dilutions of these stock solutions administered to cell cultures always resulted in a DMSO concentration below 0.5%.
| T-and E-Screen assays
While the E-Screen allows the determination of oestrogenic effects by determining oestrogen receptor-mediated cell proliferation of MCF-7 cells, the T-Screen assay allows determination of TR agonist effects by monitoring TR-mediated cell proliferation of GH3 cells. The T-and EScreen tests were conducted in a comparable manner as previously described (Soto et al., 1995) except that the treatments were terminated using an MTT assay (Mosmann, 1983) . Briefly, cells were seeded into 48-well plates (Dutscher Scientific, Brentwood, Essex, UK) at a density of 20 000 cells per well in 250 μl maintenance medium. The test medium for the E-Screen consisted of phenol red-free DMEM supplemented with 5% charcoal stripped FBS (Life Technologies), 2 mM glutamine (GE Healthcare Life Sciences) and 10 μg ml −1 penicillin/ streptomycin (Life Technologies). For the T-Screen assay, PCM medium was employed (Sirbasku, Pakala, Sato, & Eby, 1991) . PCM medium is composed of DMEM-F12 (Life Technologies) supplemented with 2 mM glutamine, 10 μg ml −1 penicillin/streptomycin, 10 μg ml −1 insulin from bovine pancreas, 10 μM ethanolamine, 10 ng ml −1 sodium selenite, 500 μg ml −1 bovine serum albumin and 10 μg human apotransferrin.
Following a 24 hour incubation to allow cell attachment and clearance of steroid hormone residues, medium was changed to that containing the desired compounds.
The test medium for both theT-and E-Screen assays was refreshed after 3 days. Following another 3 day period of incubation, an MTT assay was performed as follows. The test medium was removed and the cells were incubated with 250 μl of MTT solution (1 mg ml −1 ) for 2 hours and then lysed by the addition of 250 μl of DMSO. Optical density was measured at 570 nm using the SPECTROstar Nano plate reader (BMG Labtech, Aylesbury, Bucks, UK). Oestradiol and T 3 were used as positive controls for oestrogen and TR agonist measurements respectively.
| Adipogenesis assay
For differentiation of 3T3-L1 cultures to adipocytes, cells were seeded into 96-well plates (Dutscher Scientific) at a density of 20 000 cells per well in 100 μl maintenance medium. Following a 2 day stabilization period, they were switched to differentiation medium consisting of DMEM supplemented with 2 mM glutamine, 10 μg ml −1 penicillin/streptomycin, 10% fetal bovine calf serum (GE Healthcare Life Sciences), 500 μM 3isobutyl1methylxanthine (Sigma-Aldrich Ltd) and 100 nM insulin from bovine pancreas (Sigma-Aldrich Ltd). After a further 2 day incubation, the medium was refreshed but lacked insulin and contained various concentrations of the test neonicotinoids. 
| ToxCast data mining
Publically available data from the Toxicity Forecaster (ToxCast) program were scrutinized using the iCSS ToxCast Dashboard (http://actor.epa. 
| Statistical analysis
Results were expressed as the mean ± standard deviations of the percentage of the control cell culture receiving no treatment. The different assays were performed three times in triplicate (n = 3).
| RESULTS
The aim of this investigation was to test the endocrine disrupting effects of seven principal neonicotinoid insecticides compared to natural hormones. First, we used an oestrogen-mediated proliferation assay using MCF-7 cells (E-Screen) to evaluate oestrogenic effects.
The E-Screen assay was highly sensitive to the natural hormone as oestradiol provoked a maximum 850% increase in MCF-7 cell numbers. Contrastingly, no proliferative effect was observed with the seven neonicotinoids tested (Figure 2 ). Although they are negative for oestrogenic effects, these results were nevertheless informative regarding the differential toxicity of these insecticides as the MTT assay used to terminate the E-Screen is also a well-established determinant of cytotoxicity. Although some of the neonicotinoids, namely thiamethoxam, dinotefuran and nitenpyram produced only a small decrease in cell viability at concentrations up to 300 mg l 
| DISCUSSION
To the best of our knowledge, the study we present here constitutes the first investigation of the oestrogenic, thyroidogenic and adipogenic potential of seven frequently used neonicotinoid insecticides. Our study shows that imidacloprid could be a potential obesogen as it promoted lipid accumulation in 3T3-L1 cells that had undergone differentiation to adipocytes (Figures 4 and 5 ). This confirmed observations made in a previous study showing that imidacloprid treatment stimulated lipid accumulation in 3T3-L1 adipocytes (Park et al., 2013) . In an in vivo study, imidacloprid was found to promote adiposity in female C57BL/6 J mice (Park et al., 2013) .
Although most neonicotinoids have a comparable mode of action in insects, it is remarkable that despite their structural similarities (Figure 1) , the other six neonicotinoids tested in this study failed to The hormone-dependent proliferation assays (T-and E-Screen) showed that the seven neonicotinoids we tested are unlikely to activate oestrogen receptors and TRs (Figures 2 and 3) . It has been reported that imidacloprid can have TR agonist effects in a GH3 luciferase reporter gene assay (Xiang et al., 2017) . This observation would appear to contradict the findings we present here; however, upon close scrutiny of the data presented by Xiang and colleagues, the response to imidacloprid in their reporter gene assay was very weak (less than twofold of the control) (Xiang et al., 2017) . Thus, this poor efficiency of interaction with the TR may be insufficient to provoke a physiological response such as cell proliferation in a T-Screen as we present.
Another investigation concluded that imidacloprid disrupted the pituitary-thyroid axis of the wildlife avian species, red munia, at an environmentally relevant concentration (Pandey & Mohanty, 2015) .
However, the authors did not test imidacloprid but a commercial formulation containing multiple ingredients such as 1-methyl-2-pyrrolidinone. It is thus not possible to attribute definitely the toxic effects observed to imidacloprid, particularly as 1-methyl-2-pyrrolidinone is a known developmental toxicant, which can cause malformations such as incomplete ossification of the skull in rats (Saillenfait, Gallissot, Langonne, & Sabate, 2002) . On a related note, the commercial pesticide formulation Confidor is at least 10 times more toxic than imidacloprid alone to placental, embryonic and were linearly correlated to the concentrations of ethoxylated tallow amine adjuvants present in the formulations (Mesnage, Bernay, & Seralini, 2013) . This highlights a general problem in the field of pesticide toxicology. Authors frequently fail to distinguish between the commercial formulations and their active ingredients, leading to confusion in the scientific literature and within regulatory circles, and misrepresentation of the safety profile of marketed pesticides (Mesnage & Antoniou, 2017) .
A limitation of our study is that we do not directly assess the bind-
ing of the neonicotinoids we tested to hormone and other nuclear Although our results suggest a lack of short-term effects on hormone receptor activation for the seven neonicotinoids tested here (except for imidacloprid and adipogenicity), it is important not to ignore the possibility of effects arising from long-term exposure, which are the most typical scenario for endocrine disruptors. Assessment of outcomes from chronic exposure should be undertaken in laboratory animals in accordance with OECD guidelines, as there are no validated assays available to assess the long-term effects of pollutants in cell lines in vitro. In addition, some chemical compounds have J-or inverted J-shaped dose-responses, which become detectable with high confidence with a large number of replicates. This is the case of the hCAR inhibitor-agonist effects of 4-aminoazobenzene, which were detected after completion of 37 replicates (Bogen, 2017) . In general, endocrine disrupting chemicals can have pleiotropic effects because they can bind to different receptors with different affinities causing non-monotonic dose-responses (Vandenberg, 2014 ).
In conclusion, the seven neonicotinoid insecticides we tested were neither oestrogenic nor thyroidogenic in cell proliferation assays.
On the other hand, we observed indications of adipogenic effects mediated by the activation of PXR by imidacloprid. Our data confirm that at least one neonicotinoid insecticide can have effects on mammalian physiology. Thus, evaluation of their non-target effects should move beyond the assumption that their only potential targets are nicotinic acetylcholine receptors.
